Hepatitis B infection and vaccination among high-risk noninjection drug-using women: Baseline data from the UNITY study

Sexually Transmitted Diseases

Volumn 34, Issue 11, 2007, Pages 917-922

  Koblin, Beryl A ^a   Xu, Guozhen ^a   Lucy, Debbie ^a   Robertson, Verna ^a   Bonner, Sebastian ^b   Hoover, Donald R ^c   Fortin, Princess ^b   Latka, Mary ^b  

^a NEW YORK BLOOD CENTER   (United States)

^b NEW YORK ACADEMY OF MEDICINE   (United States)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG USE; FEMALE; HEPATITIS B; HIGH RISK POPULATION; HUMAN; RISK FACTOR; SEROLOGY; VACCINATION; VIRUS TRANSMISSION; WOMEN'S HEALTH;

ADULT; DATABASES, FACTUAL; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; MIDDLE AGED; NEW YORK CITY; PATIENT ACCEPTANCE OF HEALTH CARE; QUESTIONNAIRES; SUBSTANCE-RELATED DISORDERS; VACCINATION;

EID: 37349092669     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3180ca8f12     Document Type: Article

References (38)

1. Incidence of acute hepatitis B - United States, 1990-2002. MMWR Morb Mortal Wkly Rep 2004; 52:1252-1254.
2. Alter MJ, Hadler SC, Margolis HS, et al. The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies. JAMA 1990; 263:1218-1222.
3. McQuillan GM, Coleman PJ, Kruszon-Moran D, et al. Prevalence of hepatitis B virus infection in the United States: The National Health and Nutrition Examination Surveys, 1976 through 1994. Am J Public Health 1999; 89:14-18.
4. Weinstock HS, Bolan G, Moran JS, et al. Routine hepatitis B vaccination in a clinic for sexually transmitted diseases. Am J Public Health 1995; 85:846-849.
5. Thomas DL, Cannon RO, Shapiro CN, et al. Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases. J Infect Dis 1994; 169:990-995.
6. Mak R, Traen A, Claeyssens M, et al. Hepatitis B vaccination for sex workers: Do outreach programmes perform better? Sex Transm Infect 2003; 79:157-159.
7. Advisory Committee on Immunization Practices. Recommendations for protection against viral hepatitis. MMWR Morb Mortal Wkly Rep 1985; 34:313-335.
8. Centers for Disease Control and Prevention. Update on hepatitis B prevention. MMWR Morb Mortal Wkly Rep 1987; 353-360, 366.
9. Advisory Committee on Immunization Practices. Hepatitis B virus: A comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: Recommendations of the Immunization Practices Advisory Committee. MMWR Morb Mortal Wkly Rep 1991; 40:1-25.
10. Hepatitis B vaccination coverage among adults - United States, 2004. MMWR Morb Mortal Wkly Rep 2006; 55:509-511.
11. Mast EE, Weinbaum CM, Fiore AE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP), Part 2: Immunization of adults. MMWR Recomm Rep 2006; 55:1-33.
12. Carey J, Perlman DC, Friedmann P, et al. Knowledge of hepatitis among active drug injectors at a syringe exchange program. J Subst Abuse Treat 2005; 29:47-53.
13. Samoff E, Dunn A, VanDevanter N, et al. Predictors of acceptance of hepatitis B vaccination in an urban sexually transmitted diseases clinic. Sex Transm Dis 2004; 31:415-420.
14. Ompad DC, Galea S, Wu Y, et al. Acceptance and completion of hepatitis B vaccination among drug users in New York City. Commun Dis Public Health 2004; 7:294-300.
15. Budd J, Robertson R, Elton R. Hepatitis B vaccination and injecting drug users. Br J Gen Pract 2004; 54:444-447.
16. Lum PJ, Ochoa KC, Hahn JA, et al. Hepatitis B virus immunization among young injection drug users in San Francisco, Calif: The UFO Study. Am J Public Health 2003; 93:919-923.
17. Moses S, Mestery K, Kaita KD, et al. Viral hepatitis in a Canadian street-involved population. Can J Public Health 2002; 93:123-128.
18. Hepatitis B vaccination among high-risk adolescents and adults - San Diego, California, 1998-2001. MMWR Morb Mortal Wkly Rep 2002; 51:618-621.
19. Sellors J, Zimic-Vincetic M, Howard M, et al. Lack of compliance with hepatitis B vaccination among Canadian STD clinic patients: Candidates for an accelerated immunization schedule? Can J Public Health 1997; 88:210-211.
20. Zimet GD, Kee R, Winston Y, et al. Acceptance of hepatitis B vaccination among adult patients with sexually transmitted diseases. Sex Transm Dis 2001; 28:678-680.
21. Dal Re R, Gonzalez A, Ramirez V, et al. Compliance with immunization against hepatitis B. A pragmatic study in sexually transmitted disease clinics. Vaccine 1995; 13:163-167.
22. Hagan H, Thiede H, McGough JP, et al. Hepatitis B vaccination among research participants, Seattle, Washington. Am J Public Health 2002; 92:1756.
23. Trubatch BN, Fisher DG, Cagle HH, et al. Vaccination strategies for targeted and difficult-to-access groups. Am J Public Health 2000; 90:447.
24. Willis BC, Ndiaye SM, Hopkins DP, et al. Improving influenza, pneumococcal polysaccharide, and hepatitis B vaccination coverage among adults aged <65 years at high risk: A report on recommendations of the Task Force on Community Preventive Services. MMWR Recomm Rep 2005; 54:1-11.
25. Mezzelani P, Venturini L, Turrina G, et al. High compliance with a hepatitis B virus vaccination program among intravenous drug users. J Infect Dis 1991; 163:923.
26. Lugoboni F, Migliozzi S, Schiesari F, et al. Immunoresponse to hepatitis B vaccination and adherence campaign among injecting drug users. Vaccine 1997; 15:1014-1016.
27. Des Jarlais DC, Fisher DG, Newman JC, et al. Providing hepatitis B vaccination to injection drug users: Referral to health clinics vs on-site vaccination at a syringe exchange program. Am J Public Health 2001; 91:1791-1792.
28. Seal KH, Ochoa KC, Hahn JA, et al. Risk of hepatitis B infection among young injection drug users in San Francisco: Opportunities for intervention. West J Med 2000; 172:16-20.
29. Bodenheimer HC Jr, Fulton JP, Kramer PD. Acceptance of hepatitis B vaccine among hospital workers. Am J Public Health 1986; 76:252-255.
30. Crossley KB, Gerding DN, Petzel RA. Acceptance of hepatitis B vaccine by hospital personnel. Infect Control 1985; 6:147-149.
31. Israsena S, Kamolratanakul P, Sakulramrung R. Factors influencing acceptance of hepatitis B vaccination by hospital personnel in an area hyperendemic for hepatitis B. Am J Gastroenterol 1992; 87:1807-1809.
32. Altice FL, Bruce RD, Walton MR, et al. Adherence to hepatitis B virus vaccination at syringe exchange sites. J Urban Health 2005; 82:151-161.
33. Koblin BA, Heagerty P, Sheon A, et al. Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United States. AIDS 1998; 12:785-793.
34. Kottiri BJ, Friedman SR, Euler GL, et al. A community-based study of hepatitis B infection and immunization among young adults in a high-drug-use neighborhood in New York City. J Urban Health 2005; 82:479-487.
35. Trepka MJ, Weisbord JS, Zhang G, et al. Hepatitis B virus infection risk factors and immunity among sexually transmitted disease clinic clients. Sex Transm Dis 2003; 30:914-918.
36. Hwang LY, Ross MW, Zack C, et al. Prevalence of sexually transmitted infections and associated risk factors among populations of drug abusers. Clin Infect Dis 2000; 31:920-926.
37. Banatvala JE, Van Damme P. Hepatitis B vaccine - do we need boosters? J Viral Hepat 2003; 10:1-6.
38. Bauer T, Jilg W. Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination. Vaccine 2006; 24:572-577.